Answers are grounded in this paper and cite their sources.
Gestational trophoblastic neoplasia (GTN) comprises a group of malignant disorders arising from abnormal proliferation of trophoblastic tissue, most commonly following a molar pregnancy. Despite its high curability, early diagnosis relies on careful postmolar surveillance and appropriate interpretation of serum beta-human chorionic gonadotropin (β-hCG) trends. We report the case of a woman who developed post-molar gestational trophoblastic neoplasia during follow-up after uterine evacuation for molar pregnancy. The diagnosis was established based on persistently elevated and rising β-hCG levels, fulfilling FIGO diagnostic criteria. Imaging studies were performed to exclude metastatic disease, and the patient was staged accordingly. Risk stratification using the WHO scoring system classified the disease as low risk. The patient was treated with first-line single-agent chemotherapy using methotrexate, achieving normalization of β-hCG levels and complete remission. Consolidation therapy was administered, followed by close surveillance with serial β-hCG monitoring. This case highlights the importance of strict postmolar follow-up and early recognition of abnormal β-hCG kinetics. Prompt diagnosis and appropriate risk-based treatment allow for excellent outcomes. Single-agent chemotherapy remains highly effective in low-risk GTN, emphasizing the role of standardized management and multidisciplinary care.
No takes yet. Share an insight, caveat, or question.
Servetto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: